PathoQuest is a biotechnology company identifying pathogens through High Throughput Sequencing (HTS).
PathoQuest has raised €19M across 2 funding rounds from 9 investors, most recently a Series B round in Nov 2021. Based in Paris, France; founded 2007; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2021-11-10 | Series B | €15M | Aurinvest,Charles River Laboratories,Eurazeo,Kurma Partners,Sham,SHS Capital+2 more | View deal → |
| 2013-07-01 | Other | €4.5M | IDInvest Partners | View deal → |
